Stay updated on Neoadjuvant Combo SHR6390+Anastrozole+Pyrotinib+Trastuzumab Clinical Trial
Sign up to get notified when there's something new on the Neoadjuvant Combo SHR6390+Anastrozole+Pyrotinib+Trastuzumab Clinical Trial page.

Latest updates to the Neoadjuvant Combo SHR6390+Anastrozole+Pyrotinib+Trastuzumab Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference5%
- Check44 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference5%
- Check51 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
- Check66 days agoChange DetectedThe website has been updated from version v2.14.0 to v2.14.1.SummaryDifference0.3%
- Check73 days agoChange DetectedThe website has updated the intervention type information to 'Verified 2020-01 by Ruijin Hospital' and noted that the last known status is 'Not yet recruiting', while the previous revision (v2.13.3) has been removed.SummaryDifference3%
- Check102 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
Stay in the know with updates to Neoadjuvant Combo SHR6390+Anastrozole+Pyrotinib+Trastuzumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neoadjuvant Combo SHR6390+Anastrozole+Pyrotinib+Trastuzumab Clinical Trial page.